Venous leg ulcers (VLUs) are a challenging condition for providers; they are a complication of chronic venous disease resulting from venous valvular incompetence and venous hypertension. In this article, Robert Klein, DPM, presents an overview of VLU clinical presentation and diagnosis, possible treatment plans, and a report of an elderly patient with a VLU of the left leg.
Dr. Alonso describes his case study poster (Use of an Innovative Synthetic Self-Assembling Peptide Matrix in the Treatment of Three Large Recalcitrant 20-Year-Old Venous Leg Ulcers).
Dr. Alonso describes his case study poster (Use of an Innovative Synthetic Self-Assembling Peptide Matrix in the Treatment of Three Large Recalcitrant 20-Year-Old Venous Leg Ulcers).
Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA; Adam J. Singer; Cyaandi R. Dove, DPM; Yaron Shoham; Edward Grant; Garth A. James; Aya Ben Yaakov; Stephen Heisler; Elinor deLancey Pulcini; Lior Rosenberg; Howard Petusevsky
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
John C. Lantis, II, MD, FACS; Allegra Fierro, MD; Callie Horn, MD
The authors discuss the support that negative pressure wound therapy can provide in the treatment of venous leg ulcers as well as an algorithm for increased use of the modality in this indication.
The authors discuss the support that negative pressure wound therapy can provide in the treatment of venous leg ulcers as well as an algorithm for increased use of the modality in this indication.
In this interview, Dr. Callie Horn speaks on the topic of compression and some considerations the clinician should keep in mind when determining the most appropriate type of compression.
In this interview, Dr. Callie Horn speaks on the topic of compression and some considerations the clinician should keep in mind when determining the most appropriate type of compression.
This study compared healing and periwound skin condition in patients with venous leg ulcers when treated with zinc barrier cream compared to advanced elastomeric skin protectant.
This study compared healing and periwound skin condition in patients with venous leg ulcers when treated with zinc barrier cream compared to advanced elastomeric skin protectant.
A 62-year-old female with a chronic venous leg ulcer of 2 years' duration achieved full wound closure 2 months after a combination of negative pressure wound therapy with instillation, hydrosurgery, and split-thickness skin graft.
A 62-year-old female with a chronic venous leg ulcer of 2 years' duration achieved full wound closure 2 months after a combination of negative pressure wound therapy with instillation, hydrosurgery, and split-thickness skin graft.
Dr. Alonso describes his case study poster (Use of an Innovative Synthetic Self-Assembling Peptide Matrix in the Treatment of Three Large Recalcitrant 20-Year-Old Venous Leg Ulcers).
Dr. Alonso describes his case study poster (Use of an Innovative Synthetic Self-Assembling Peptide Matrix in the Treatment of Three Large Recalcitrant 20-Year-Old Venous Leg Ulcers).
In this interview, Dr. Callie Horn speaks on the topic of compression and some considerations the clinician should keep in mind when determining the most appropriate type of compression.
In this interview, Dr. Callie Horn speaks on the topic of compression and some considerations the clinician should keep in mind when determining the most appropriate type of compression.
Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA
In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
In this poster presentation video, the presenter reports on the use of negative pressure wound therapy with instillation and dwell time in 3 cases of lower extremity wounds.
In this poster presentation video, the presenter reports on the use of negative pressure wound therapy with instillation and dwell time in 3 cases of lower extremity wounds.
Alton R. Johnson, Jr., DPM, DABPM, FACPM, FASPS, CWSP
Finalized CMS pricing and regulatory changes for cellular and tissue-based products (CTPs) are expected to significantly alter where—and how—wound care is delivered. In this interview, Alton R. Johnson, Jr., DPM, explains why private...
Finalized CMS pricing and regulatory changes for cellular and tissue-based products (CTPs) are expected to significantly alter where—and how—wound care is delivered. In this interview, Alton R. Johnson, Jr., DPM, explains why private...
In this video discussion, Chris Boodoo, MSc, and Karen Cross, MD, PhD, discuss how technology companies keep up with the uncertainty surrounding cellular- and tissue-based products (CTPs).
In this video discussion, Chris Boodoo, MSc, and Karen Cross, MD, PhD, discuss how technology companies keep up with the uncertainty surrounding cellular- and tissue-based products (CTPs).
As Dr. Fife notes, reduced margins may challenge home-based care previously supported by higher product profits; however, low-cost products can still yield margins, especially for large wounds,
As Dr. Fife notes, reduced margins may challenge home-based care previously supported by higher product profits; however, low-cost products can still yield margins, especially for large wounds,
With tightening skin substitute reimbursement and increasing regulatory scrutiny, many are questioning whether mobile wound care remains sustainable. Drawing on real-world experience, this discussion reframes sustainability as a...
With tightening skin substitute reimbursement and increasing regulatory scrutiny, many are questioning whether mobile wound care remains sustainable. Drawing on real-world experience, this discussion reframes sustainability as a...
In Part 2 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research confront the emotional and operational fallout of intensified fraud, waste, and abuse scrutiny in wound care—particularly as it relates...
In Part 2 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research confront the emotional and operational fallout of intensified fraud, waste, and abuse scrutiny in wound care—particularly as it relates...
Dr. Fife discusses the effects of CTP changes on hospital-based, mobile clinicians, skilled nursing and other settings, also touching on considerations with product handling.
Dr. Fife discusses the effects of CTP changes on hospital-based, mobile clinicians, skilled nursing and other settings, also touching on considerations with product handling.
In part 1 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research examine how mobile wound care has been reshaped by the rapid rise of cellular and acellular matrix products (CAMPs)/skin substitutes.
In part 1 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research examine how mobile wound care has been reshaped by the rapid rise of cellular and acellular matrix products (CAMPs)/skin substitutes.
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
This speaker discusses how CTP changes affect various stakeholders, how prepared providers will be, whether regulatory efforts are fostering or stifling innovation, and what policy actions would ensure sustainable growth and fair competition...
This speaker discusses how CTP changes affect various stakeholders, how prepared providers will be, whether regulatory efforts are fostering or stifling innovation, and what policy actions would ensure sustainable growth and fair competition...
Dr. Alonso describes his case study poster (Use of an Innovative Synthetic Self-Assembling Peptide Matrix in the Treatment of Three Large Recalcitrant 20-Year-Old Venous Leg Ulcers).
Dr. Alonso describes his case study poster (Use of an Innovative Synthetic Self-Assembling Peptide Matrix in the Treatment of Three Large Recalcitrant 20-Year-Old Venous Leg Ulcers).
Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA; Adam J. Singer; Cyaandi R. Dove, DPM; Yaron Shoham; Edward Grant; Garth A. James; Aya Ben Yaakov; Stephen Heisler; Elinor deLancey Pulcini; Lior Rosenberg; Howard Petusevsky
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.
In this interview, Dr. Callie Horn speaks on the topic of compression and some considerations the clinician should keep in mind when determining the most appropriate type of compression.
In this interview, Dr. Callie Horn speaks on the topic of compression and some considerations the clinician should keep in mind when determining the most appropriate type of compression.
This study compared healing and periwound skin condition in patients with venous leg ulcers when treated with zinc barrier cream compared to advanced elastomeric skin protectant.
This study compared healing and periwound skin condition in patients with venous leg ulcers when treated with zinc barrier cream compared to advanced elastomeric skin protectant.
A 62-year-old female with a chronic venous leg ulcer of 2 years' duration achieved full wound closure 2 months after a combination of negative pressure wound therapy with instillation, hydrosurgery, and split-thickness skin graft.
A 62-year-old female with a chronic venous leg ulcer of 2 years' duration achieved full wound closure 2 months after a combination of negative pressure wound therapy with instillation, hydrosurgery, and split-thickness skin graft.
Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA
In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...
Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...
Alton R. Johnson, Jr., DPM, DABPM, FACPM, FASPS, CWSP
Finalized CMS pricing and regulatory changes for cellular and tissue-based products (CTPs) are expected to significantly alter where—and how—wound care is delivered. In this interview, Alton R. Johnson, Jr., DPM, explains why private...
Finalized CMS pricing and regulatory changes for cellular and tissue-based products (CTPs) are expected to significantly alter where—and how—wound care is delivered. In this interview, Alton R. Johnson, Jr., DPM, explains why private...
In this video discussion, Chris Boodoo, MSc, and Karen Cross, MD, PhD, discuss how technology companies keep up with the uncertainty surrounding cellular- and tissue-based products (CTPs).
In this video discussion, Chris Boodoo, MSc, and Karen Cross, MD, PhD, discuss how technology companies keep up with the uncertainty surrounding cellular- and tissue-based products (CTPs).
As Dr. Fife notes, reduced margins may challenge home-based care previously supported by higher product profits; however, low-cost products can still yield margins, especially for large wounds,
As Dr. Fife notes, reduced margins may challenge home-based care previously supported by higher product profits; however, low-cost products can still yield margins, especially for large wounds,
With tightening skin substitute reimbursement and increasing regulatory scrutiny, many are questioning whether mobile wound care remains sustainable. Drawing on real-world experience, this discussion reframes sustainability as a...
With tightening skin substitute reimbursement and increasing regulatory scrutiny, many are questioning whether mobile wound care remains sustainable. Drawing on real-world experience, this discussion reframes sustainability as a...
In Part 2 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research confront the emotional and operational fallout of intensified fraud, waste, and abuse scrutiny in wound care—particularly as it relates...
In Part 2 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research confront the emotional and operational fallout of intensified fraud, waste, and abuse scrutiny in wound care—particularly as it relates...
Dr. Fife discusses the effects of CTP changes on hospital-based, mobile clinicians, skilled nursing and other settings, also touching on considerations with product handling.
Dr. Fife discusses the effects of CTP changes on hospital-based, mobile clinicians, skilled nursing and other settings, also touching on considerations with product handling.
In part 1 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research examine how mobile wound care has been reshaped by the rapid rise of cellular and acellular matrix products (CAMPs)/skin substitutes.
In part 1 of this interview series, Zwelithini Tunyiswa, BS, and Ryan Dirks, PA-C, of Open Wound Research examine how mobile wound care has been reshaped by the rapid rise of cellular and acellular matrix products (CAMPs)/skin substitutes.
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
CMS reimbursement reforms are reshaping the use of skin substitutes in wound care, phasing out high-cost, low-evidence products in favor of therapies backed by rigorous clinical data. New models like WISeR promote prior authorization to...
This speaker discusses how CTP changes affect various stakeholders, how prepared providers will be, whether regulatory efforts are fostering or stifling innovation, and what policy actions would ensure sustainable growth and fair competition...
This speaker discusses how CTP changes affect various stakeholders, how prepared providers will be, whether regulatory efforts are fostering or stifling innovation, and what policy actions would ensure sustainable growth and fair competition...
A poster presented at SAWC Fall summarizes a study on burn wound healing among patients with diabetes to examine how different A1c levels correlate with complications and prolonged healing.
A poster presented at SAWC Fall summarizes a study on burn wound healing among patients with diabetes to examine how different A1c levels correlate with complications and prolonged healing.
